Your provider will screen for contraindications and drug interactions as part of the consultation
GBA1 encodes for the lysosomal glucocerebrosidase (GCase), an enzyme involved in cellular waste elimination
Orforglipron, for which a domestic patent has been granted, is an orally (ingestible) administered small-molecule compound currently under development by the multinational pharmaceutical company Eli Lilly and belongs to the glucagon-like peptide 1 (GLP-1) class of drugs
Popular GLP-1 medications Some of the most well-known GLP-1 drugs include: Semaglutide: Sold under the names Ozempic and Wegovy by manufacturer Novo Nordisk Tirzepatide: Technically a dual GLP-1/GIP agonist, sold as Mounjaro and Zepbound, developed by Eli Lilly Liraglutide: Sold as Saxenda and Victoza (and generically), also manufactured by Novo Nordisk Forms of GLP-1 medications and FDA approval Injections : The name-brand medications listed above have all been FDA approved , but only in injectable form
Unfortunately, your bodys response is an overreaction in this case, and the sudden and excessive dump of insulin is too much for the amount of sugar, which leads to a drop in your blood sugar